Treatment of incontinence with 5-HT2C agonists

Details for Australian Patent Application No. 2010203093 (hide)

International Classifications

Event Publications

5 August 2010 Complete Application Filed

12 August 2010 Application Open to Public Inspection

Published as AU-A-2010203093

14 October 2010 Section 223 Application Allowed

Pfizer Inc. The time in which to make a further application for a divisional patent has been extended to 25 Jul 2010. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.